FIB4 usefulness for measuring fibrosis changes following anti-HCV - Viral treatment

被引：0
|
作者：
Nalpas, Bertrand
Fontaine, Helene
Vallet-Pichard, Anais
Mallet, Vincent
Verkarre, Virginie
Pol, Stanislas
机构：
[1] Hop Cochin, Liver Unit, Paris, France
[2] Hop Cochin, INSERM, U567, F-75674 Paris, France
[3] Hop Necker Enfants Malad, Serv Anat Pathol, Paris, France
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1357
引用
收藏
页码：842A / 843A
页数：2
相关论文
共 32 条
  • [21] Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data fromthe Italian Platform for the Study of Viral Hepatitis Therapies (PITER)
    Kondili, L. A.
    Di Leo, A.
    Iannone, A.
    Santantonio, T.
    Giammario, A.
    Raimondo, G.
    Filomia, R.
    Coppola, C.
    Amoruso, D.
    Blanc, P.
    Del Pin, B.
    Chemello, L.
    Cavalletto, L.
    Morisco, F.
    Donnarumma, L.
    Rumi, M. G.
    Gasbarrini, A.
    Siciliano, M.
    Massari, M.
    Corsini, R.
    Brunetto, M. R.
    Coco, B.
    Madonia, S.
    Zignego, A. L.
    Monti, M.
    Russo, F. P.
    Zanetto, A.
    Persico, M.
    Masarone, M.
    Villa, E.
    Bernabucci, V.
    Taliani, G.
    Biliotti, E.
    Chessa, L.
    Pasetto, M. C.
    Andreone, P.
    Margotti, M.
    Gaeta, G. B.
    Rizzo, V.
    Ieluzzi, D.
    Borgia, G.
    Zappulo, E.
    Calvaruso, V.
    Petta, S.
    Rolli, F. R.
    Falzano, L.
    Rosato, S.
    Ruggeri, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S535 - S536
  • [22] DIRECT ANTIVIRAL AGENT TREATMENT OF CHRONIC HCV INFECTION RESULTS IN RAPID REGRESSION OF TRANSIENT ELASTOGRAPHY (FIBROSCAN®) AND VALIDATED FIBROSIS MARKERS FIB-4 AND APRI
    Bachofner, J. A.
    Valli, P. V.
    Kroger, A.
    Mullhaupt, B.
    Mertens, J. C.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S724 - S724
  • [23] CHANGES IN INTERFERON-GAMMA INDUCIBLE PROTEIN-10 IN TREATMENT-NAIVE VERSUS TREATMENT-EXPERIENCED PATIENTS GIVEN AN ALL-ORAL ANTI-HCV REGIMEN
    Lin, J. C.
    Afdhal, N.
    Lawitz, E. J.
    Paulson, M. S.
    Zhu, Y.
    Subrmanian, G. M.
    McHutchison, J. G.
    Sulkowski, M.
    Wyles, D. L.
    Schooley, R. T.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S193 - S193
  • [24] Treatment of chronic HCV Infection with direct antiviral agents (DAA) results in rapid regression of transient elastography (Fibroscan®) and validated fibrosis markers FIB-4 and APRI
    Bachofner, Jacqueline A.
    Bergamin, Irina
    Valli, Piero V.
    Kroger, Arne
    Kunzler, Patrizia
    Baserga, Adriana
    Braun, Dominique L.
    Fehr, Jan
    Semela, David
    Magenta, Lorenzo
    Mullhaupt, Beat
    Terzirolli, Benedetto
    Mertens, Joachim C.
    HEPATOLOGY, 2016, 64 : 951A - 952A
  • [25] Changes in HCV specific CD4+ responses during treatment with pegylated interferon-α and ribavirin correlate with viral response
    Brooks, CL
    Sanders, EA
    Hadfield, S
    Green, S
    Rosenberg, WM
    GUT, 2002, 50 : A48 - A48
  • [26] Dynamic changes of serum M2BPGi as a fibrosis marker of patients with HCV mono-infection and HCV/HIV co-infection receiving direct-acting anti-viral therapy
    Chuaypen, Natthaya
    Chittmittrapap, Salyavit
    Avihingsanon, Anchalee
    Tangkijvanich, Pisit
    JOURNAL OF HEPATOLOGY, 2020, 73 : S621 - S622
  • [27] Sustained virologic response and changes in liver fibrosis parameters following 12-wk administration of generic sofosbuvir and daclatasvir in HIV/HCV-coinfected patients with HCV genotype 4 infection
    Cordie, Ahmed
    Elsharkawy, Aisha
    Alem, Shereen Abdel
    Meshaal, Safa
    El Akel, Wafaa
    Abdellatif, Zeinab
    Kamal, Walid
    Al Askalany, Mahmoud
    Kamel, Sherif
    Aziz, Hossam Abdel
    Kandeel, Amr
    Esmat, Gamal
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2020, 114 (04) : 232 - 240
  • [28] Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn's disease: Changes following treatment with immunomodulators and/or anti-TNF antibodies
    Moreno, Nadia
    Ripolles, Tomas
    Maria Paredes, Jose
    Ortiz, Inmaculada
    Martinez, Maria Jesus
    Lopez, Antonio
    Delgado, Fructuoso
    Moreno-Osset, Eduardo
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (09): : 1079 - 1087
  • [29] Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt
    El Kassas, M.
    Funk, A. L.
    Abd El Latif, Y.
    Vasiliu, A.
    Sherief, A.
    Shimakawa, Y.
    Youssef, N.
    El Tahan, A.
    Elbadry, M.
    Farid, A. M.
    El Shazly, Y.
    Doss, W.
    Esmat, G.
    Fontanet, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (11) : 1564 - 1566
  • [30] Synthesis and Anti-HCV Activities of 4′-Fluoro-2′-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4′-Fluoro-2′-C-methyluridine 5′-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection
    Wang, Guangyi
    Dyatkina, Natalia
    Prhavc, Marija
    Williams, Caroline
    Serebryany, Vladimir
    Hu, Yujian
    Huang, Yongfei
    Wan, Jinqiao
    Wu, Xiangyang
    Deval, Jerome
    Fung, Amy
    Jin, Zhinan
    Fan, Hua
    Shaw, Kenneth
    Kang, Hyunsoon
    Zhang, Qingling
    Tam, Yuen
    Stoycheva, Antitsa
    Jekle, Andreas
    Smith, David B.
    Beigelman, Leonid
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (09) : 4555 - 4570
1234